What are the future prospects for polycythemia vera pharmacotherapies for patients with hydroxyurea resistance?

Megan Metzger; John Mascarenhas

doi:10.1080/14656566.2024.2396029

What are the future prospects for polycythemia vera pharmacotherapies for patients with hydroxyurea resistance?

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	1585-1590
Number of pages	6
Journal	Expert Opinion on Pharmacotherapy
Volume	25
Issue number	12
DOIs	https://doi.org/10.1080/14656566.2024.2396029
State	Published - 2024

Keywords

LSD1 inhibitor
Polycythemia vera
hepcidin mimetic
histone deacetylase inhibitor
hydroxyurea resistance
interferon
ruxolitinib

Access to Document

10.1080/14656566.2024.2396029

Cite this

@article{afc3e618dbb14125b2cc59fda4621bd3,

title = "What are the future prospects for polycythemia vera pharmacotherapies for patients with hydroxyurea resistance?",

keywords = "LSD1 inhibitor, Polycythemia vera, hepcidin mimetic, histone deacetylase inhibitor, hydroxyurea resistance, interferon, ruxolitinib",

author = "Megan Metzger and John Mascarenhas",

year = "2024",

doi = "10.1080/14656566.2024.2396029",

language = "English",

volume = "25",

pages = "1585--1590",

journal = "Expert Opinion on Pharmacotherapy",

issn = "1465-6566",